Supervised Exercise for Patients With Metastatic Breast Cancer ... T cells. Strategies to Boost CAR-T Cell Efficacy in CRC Fig 3. Advancements in CAR-T cell therapies for CRC. This figure illustrates ...

Today, cancer has become one of the leading global tragedies. It occurs when a small number of cells in the body mutate, causing some of them to evade the body’s immune system and proliferate ...

She had no family history of cancer. So when she experienced some swelling in her breast near the end of what she called “a textbook-easy pregnancy” with her third child, she and her doctors ...

The experts have uncovered why cancer cells respond differently to radiotherapy, with some cells dying in ways that alert the immune system and others dying silently. This difference is linked to how ...

Laboratory for Drug Design and Synthesis, Department of Pharmaceutical Sciences and Natural Products, School of Pharmaceutical Sciences, Central University of Punjab, Bathinda 151 401, India ...

Scientists at Children's Medical Research Institute (CMRI) have solved a big mystery in cancer research – why cells die in different ways following radiotherapy. This surprising finding opens up ...

Glioblastoma is typically treated with photon radiation, which uses high-energy X-rays to destroy the DNA in cancer cells, thus killing them. Usually, patients' tumors are mapped out by MRI before ...

Podcaster and author Mel Robbins has recently published a book about how letting go of expectations of others can benefit your life. (Getty Images) ...

A study published in Science Advances shares new insights into how two of the most common types of chimeric antigen receptor (CAR) T cells kill cancer. Investigators from Baylor College of ...

CAR T cells show contrasting approaches to killing cancer, with one sprinting for fast action and the other collaborating for endurance. Scientists are now focusing on adapting these cells to outsmart ...

Many cancer drugs work by inhibiting the activity of proteins — the molecules that do most of the work in the cell. But some misbehaving proteins that turn normal cells cancerous are difficult to ...